Is your child currently experiencing UC flare-ups? Local Crohn’s disease (CD) clinical research study is testing a potential new medication to see if it may reduce cramping, mouth sores, diarrhea, malnutrition, and/or liver disease associated with UC.
If you’re concerned about how UC affects your child’s life, find out more about the Crohn’s disease (CD) clinical research study.

Your child may be eligible for one of the GI studies if they are 2‒17 years of age, have been diagnosed with moderate to severe UC or CD, and have previously received treatment for UC or CD that has not worked.

By joining the GI studies, your child may receive:

• Compensation for study-related time
• Reimbursement for study-related travel
• Study-related care from local doctors
• Study medication at no cost

Health insurance is not required to take part.

Act now.

We are looking for children at least 2 years of age but under 18 to join a research to help us discover more about treating Crohn’s. If you are looking for a potential new treatment option for Crohn’s or Crohn’s and ulcerative colitis (including associated symptoms such as cramps, iron deficiency, diarrhea, malnutrition and/or joint pain), consider one of our research studies. All eligible participants will receive no-cost study-related care and study medication. Your children at least 2 years of age but under 18 may be eligible to take part.

Your child may be eligible to take part in the research studies if they:

• are 2‒17 years of age
• have been diagnosed with moderate to severe ulcerative colitis (UC) or Crohn’s disease (CD)
• have previously received treatment for UC or CD that has not worked.

Find out if your child qualifies.

Is your child currently experiencing Crohn’s disease flare-ups? Local CD study is testing a potential new medication to see if it may reduce abdominal cramping, inflammation of the bowel or intestine, bloody stool, frequent fevers, and/or joint pain associated with Crohn’s disease.
If you’re concerned about how Crohn’s disease affects your child’s life, find out more about the CD study.

Your child may be eligible for one of the GI studies if they are 2‒17 years of age, have been diagnosed with moderate to severe UC or CD, and have previously received treatment for UC or CD that has not worked.

By joining the GI studies, your child may receive:

• Compensation for study-related time
• Reimbursement for study-related travel
• Study-related care from local doctors
• Study medication at no cost

Health insurance is not required to take part.

Find out if your child qualifies.

We are looking for young people 2 to 17 years of age to join a Crohn’s disease study to help us discover more about treating moderate to severe IBD. If you are looking for a potential new treatment option for moderate to severe IBD or Crohn’s (including associated symptoms such as tiredness, iron deficiency, diarrhea, chronic fatigue and/or eye pain), consider one of our clinical research. All eligible participants will receive no-cost study-related care and study medication. Your young people 2 to 17 years of age may be eligible to take part.

Your child may be eligible to take part in the clinical research if they:

• are 2‒17 years of age
• have been diagnosed with moderate to severe ulcerative colitis (UC) or Crohn’s disease (CD)
• have previously received treatment for UC or CD that has not worked.

Is your child eligible?

Is your child currently experiencing moderately to severely active ulcerative colitis flare-ups? Local Crohn’s disease medical research study is testing a potential new medication to see if it may reduce diarrhea with blood and pus, abdominal cramps, rectal pain, frequent fevers, and/or liver disease associated with moderately to severely active ulcerative colitis.
If you’re concerned about how moderately to severely active ulcerative colitis affects your child’s life, find out more about the Crohn’s disease medical research study.

Your child may be eligible for one of the GI studies if they are 2‒17 years of age, have been diagnosed with moderate to severe UC or CD, and have previously received treatment for UC or CD that has not worked.

By joining the GI studies, your child may receive:

• Compensation for study-related time
• Reimbursement for study-related travel
• Study-related care from local doctors
• Study medication at no cost

Health insurance is not required to take part.

Is your child eligible?

We are looking for young people 2 to 17 years of age to join a study to help us discover more about treating UC. If you are looking for a potential new treatment option for UC or Crohn’s and ulcerative colitis (including associated symptoms such as bloody diarrhea, persistent diarrhea, bloody stool, malnutrition and/or canker sores), consider one of our clinical research studies. All eligible participants will receive no-cost study-related care and study medication. Your young people 2 to 17 years of age may be eligible to take part.

Your child may be eligible to take part in the clinical research studies if they:

• are 2‒17 years of age
• have been diagnosed with moderate to severe ulcerative colitis (UC) or Crohn’s disease (CD)
• have previously received treatment for UC or CD that has not worked.

See if your child qualifies.

Is your child currently experiencing Crohn’s and UC flare-ups? Local research study is testing a potential new medication to see if it may reduce joint pain, weight loss, diarrhea, chronic fatigue, and/or liver disease associated with Crohn’s and UC.
If you’re concerned about how Crohn’s and UC affects your child’s life, find out more about the research study.

Your child may be eligible for one of the GI studies if they are 2‒17 years of age, have been diagnosed with moderate to severe UC or CD, and have previously received treatment for UC or CD that has not worked.

By joining the GI studies, your child may receive:

• Compensation for study-related time
• Reimbursement for study-related travel
• Study-related care from local doctors
• Study medication at no cost

Health insurance is not required to take part.

See if your child qualifies.

We are looking for children 2–17 years old to join a CD medical research study to help us discover more about treating moderately to severely active IBD. If you are looking for a potential new treatment option for moderately to severely active IBD or moderately to severely active IBD (including associated symptoms such as stomach pain, loss of appetite, diarrhea, malnutrition and/or eye pain), consider one of our clinical trials. All eligible participants will receive no-cost study-related care and study medication. Your children 2–17 years old may be eligible to take part.

Your child may be eligible to take part in the clinical trials if they:

• are 2‒17 years of age
• have been diagnosed with moderate to severe ulcerative colitis (UC) or Crohn’s disease (CD)
• have previously received treatment for UC or CD that has not worked.

Enrolling for a limited time.

Is your child currently experiencing Crohn’s and ulcerative colitis flare-ups? Local Crohn’s disease (CD) medical research study is testing a potential new medication to see if it may reduce diarrhea with pus, fistula, constant need to poop, weight loss, and/or canker sores associated with Crohn’s and ulcerative colitis.
If you’re concerned about how Crohn’s and ulcerative colitis affects your child’s life, find out more about the Crohn’s disease (CD) medical research study.

Your child may be eligible for one of the GI studies if they are 2‒17 years of age, have been diagnosed with moderate to severe UC or CD, and have previously received treatment for UC or CD that has not worked.

By joining the GI studies, your child may receive:

• Compensation for study-related time
• Reimbursement for study-related travel
• Study-related care from local doctors
• Study medication at no cost

Health insurance is not required to take part.

Enrolling for a limited time.

We are looking for children 2–17 years of age to join a Crohn’s disease medical research study to help us discover more about treating moderate to severe ulcerative colitis. If you are looking for a potential new treatment option for moderate to severe ulcerative colitis or moderate to severe Crohn’s disease (including associated symptoms such as diarrhea with pus, unexplained weight loss, rectal pain, chronic fatigue and/or joint pain), consider one of our research. All eligible participants will receive no-cost study-related care and study medication. Your children 2–17 years of age may be eligible to take part.

Your child may be eligible to take part in the research if they:

• are 2‒17 years of age
• have been diagnosed with moderate to severe ulcerative colitis (UC) or Crohn’s disease (CD)
• have previously received treatment for UC or CD that has not worked.

Enrolling for a limited time.